DRAGARWQ5,301.00

Dr Agarwals Eye Hospital Limited

· Pharma & Health
₹ CrorePeersKMCSHILKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMED
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Non-current Assets
+ Property, Plant & Equipment314.8365.1374.8
+ Capital Work-in-Progress97.4128.0197.3
+ Goodwill0.25.75.7
+ Other Intangibles0.622.422.1
+ Other Non-current Financial Assets8.510.011.4
Non-current Financial Assets8.511.4
+ Deferred Tax Assets10.09.79.7
+ Other Non-current Assets4.314.39.0
Total Non-current Assets435.9557.4629.9
Current Assets
+ Inventories9.813.414.1
+ Current Investments14.089.1
+ Trade Receivables12.914.018.7
+ Cash & Cash Equivalents32.911.26.6
+ Other Bank Balances0.91.00.1
+ Other Current Financial Assets2.02.23.9
Current Financial Assets48.6118.4
+ Other Current Assets1.51.64.1
Total Current Assets59.855.9136.5
Total Assets495.8613.3766.5
Equity
+ Equity Share Capital4.74.74.8
+ Other Equity / Reserves152.5204.9341.5
Equity — Owners of Parent157.2209.6346.3
Total Equity157.2209.6346.3
Liabilities
+ Borrowings — Non-current44.581.867.1
+ Other Non-current Financial Liab2.42.32.3
+ Provisions — Non-current7.48.810.6
Non-current Liabilities257.8316.7308.8
+ Borrowings — Current6.814.614.7
+ Other Current Financial Liab20.322.334.0
+ Provisions — Current1.31.43.0
+ Current Tax Liabilities10.00.012.3
+ Other Current Liabilities5.25.55.0
Current Liabilities80.887.0111.4
Total Liabilities338.6403.7420.2
Total Equity & Liabilities495.8613.3766.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.